Bone densitometry developer CompuMed has received approval to market its OsteoGram system from the State Drug Administration of the People’s Republic of China. The product is a software system that utilizes hand x-ray image-processing technology to aid in the diagnosis of osteoporosis, monitor bone density change over time, and predict fracture risk.
CompuMed is touting OsteoGram as a cost-effective testing method for osteoporosis in areas where the capital acquisition costs of dual-energy x-ray absorptiometry (DEXA) scanners are prohibitive. There are approximately 129 million post-menopausal women in China who represent model candidates for the OsteoGram test, according to the firm.
By AuntMinnie.com staff writersJune 25, 2002
Related Reading
CompuMed revenues edge higher in Q2, May 15, 2002
CompuMed hires new management team, May 13, 2002
CompuMed revenues dip, February 14, 2002
CompuMed eyes international markets, February 6, 2002
Copyright © 2002 AuntMinnie.com
